Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Navigating the system to avoid tariffs on smaller orders is just too time-consuming or difficult for many entrepreneurs ...
Start by thinking about the dilemmas your people will face. by Erin Meyer At the beginning of my career, I worked for the health-care-software specialist HBOC. One day, a woman from human resources ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results